We are live on
!
Find out more
ROTUOC
Regents of the University of California Portfolio holdings
AUM
$4.36B
1-Year Est. Return
33.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.39%
1 Year Est. Return
+33.89%
3 Year Est. Return
+86.09%
5 Year Est. Return
+63.96%
10 Year Est. Return
+870.04%
AUM
$767M
AUM Growth
+$74.8M
(+11%)
Cap. Flow
+$23.2M
Cap. Flow
% of AUM
3.02%
Top 10 Holdings %
Top 10 Hldgs %
96.84%
Holding
35
New
7
Increased
1
Reduced
3
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DoorDash
DASH
|
+$23.8M |
| 2 |
Alibaba
BABA
|
+$10.8M |
| 3 |
Affirm
AFRM
|
+$5.67M |
| 4 |
Palantir
PLTR
|
+$3.29M |
| 5 |
EB
Eventbrite
EB
|
+$670K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allogene Therapeutics
ALLO
|
+$7.57M |
| 2 |
Revolution Medicines
RVMD
|
+$5.55M |
| 3 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$3.51M |
| 4 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
+$2.68M |
| 5 |
RAPT
RAPT Therapeutics
RAPT
|
+$2.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 77.81% |
| 2 | Healthcare | 9.61% |
| 3 | Consumer Discretionary | 8.96% |
| 4 | Consumer Staples | 1.39% |
| 5 | Technology | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Blue Owl Capital
OBDC
$5.75B
| $588M | 76.64% |
42,690,843
| – | – |
|
|
2
Alibaba
BABA
$300B
| $50.1M | 6.53% |
221,026
+43,954
| +25% | +$10.8M |
|
|
3
Allogene Therapeutics
ALLO
$714M
| $23.9M | 3.11% |
675,743
-224,400
| -25% | -$7.57M |
|
|
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
| $22.2M | 2.89% |
125,000
-15,280
| -11% | -$2.52M |
|
|
5
DoorDash
DASH
$92.1B
| $18.6M | 2.42% |
+141,841
| New | +$23.8M |
|
|
CNST
6
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $14.5M | 1.9% |
621,541
-115,865
| -16% | -$3.51M |
|
7
Estee Lauder
EL
$31.7B
| $9.71M | 1.27% |
33,400
| – | – |
|
8
Intellia Therapeutics
NTLA
$1.69B
| $8.94M | 1.17% |
111,440
| – | – |
|
|
9
Affirm
AFRM
$24.6B
| $4.13M | 0.54% |
+58,362
| New | +$5.67M |
|
10
Air Products & Chemicals
APD
$67.7B
| $2.87M | 0.37% |
10,200
| – | – |
|
|
11
Palantir
PLTR
$411B
| $2.8M | 0.36% |
+120,049
| New | +$3.29M |
|
12
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
| $2.67M | 0.35% |
5,600
| – | – |
|
13
S&P Global
SPGI
$121B
| $2.12M | 0.28% |
6,000
| – | – |
|
14
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.06M | 0.27% |
8,043
| – | – |
|
15
ExxonMobil
XOM
$657B
| $1.88M | 0.24% |
33,600
| – | – |
|
16
Merck
MRK
$328B
| $1.67M | 0.22% |
22,637
| – | – |
|
17
Texas Instruments
TXN
$253B
| $1.23M | 0.16% |
6,500
| – | – |
|
18
Walt Disney
DIS
$178B
| $1.11M | 0.14% |
6,000
| – | – |
|
19
Verizon
VZ
$195B
| $1.03M | 0.13% |
17,735
| – | – |
|
20
Pfizer
PFE
$150B
| $1M | 0.13% |
27,645
| – | – |
|
21
Coca-Cola
KO
$373B
| $949K | 0.12% |
18,000
| – | – |
|
22
Honeywell
HON
$74.6B
| $917K | 0.12% |
4,481
| – | – |
|
|
EB
23
DELISTED
Eventbrite
EB
| $738K | 0.1% |
+33,292
| New | +$670K |
|
24
Wells Fargo
WFC
$269B
| $707K | 0.09% |
18,106
| – | – |
|
25
AT&T
T
$166B
| $656K | 0.09% |
28,715
| – | – |
|
Similar funds
SFM
EC
EQF
NEI
FIS
CAU
IUHSA
CW
Regents of the University of California's Q1 2021 Portfolio in Review
As of Q1 2021, Regents of the University of California held 35 positions worth $767M, up 11% from $692M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Regents of the University of California deployed $23.2M of net new capital in Q1 2021, opening 7 new positions and adding to 1 existing holding. Its largest new stake was DoorDash: 141,841 shares worth $18.6M.
By sector, the portfolio is most concentrated in Financials at 78% of assets, down from 79% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Allogene Therapeutics, an estimated $7.57M trimmed.
- Regents of the University of California's largest Q1 2021 buy was DoorDash: 141,841 shares worth $18.6M.
- Regents of the University of California added most to Alibaba in Q1 2021, an estimated $10.8M increase.
- Regents of the University of California's biggest Q1 2021 reduction was Allogene Therapeutics, cutting an estimated $7.57M.
- Regents of the University of California fully exited Revolution Medicines in Q1 2021, selling an estimated $5.55M.
- Regents of the University of California's ten largest holdings make up 97% of its $767M portfolio in Q1 2021.
- Regents of the University of California opened 7 new positions and closed 3 in Q1 2021.
- Regents of the University of California's portfolio value rose 11% quarter-over-quarter to $767M.
Based on Regents of the University of California's 13F filing for Q1 2021, filed 20 Apr 2021.